Abstract
AbstractIntrahepatic cholangiocarcinoma (iCCA) exhibits different blood imaging features and prognosis depending on histology. To clarity histopathological growth patterns (HGPs) and vascularization processes of iCCA, we collected 145 surgical specimens and histologically classified them into large bile duct (LBD) (20 cases), small bile duct (SBD) (54), cholangiolocarcinoma (CLC) (35), combined SBD–CLC (cSBD–CLC) (26), and ductal plate malformation (DPM) (10) (sub)types. According to the invasive pattern at the interface between tumor and adjacent background liver, HGPs were classified into desmoplastic, pushing, and replacing HGPs. Desmoplastic HGP predominated in LBD type (55.5%), while replacing HGP was common in CLC (82.9%) and cSBD–CLC (84.6%) subtypes. Desmoplastic HGP reflected angiogenesis, while replacing HGP showed vessel co-option in addition to angiogenesis. By evaluating microvessel density (MVD) using vascular markers, ELTD1 identified vessel co-option and angiogenesis, and ELTD1-positive MVD at invasive margin in replacing HGP was significantly higher than those in desmoplastic and pushing HGPs. REDD1, an angiogenesis-related marker, demonstrated preferably higher MVD in the tumor center than in other areas. iCCA (sub)types and HGPs were closely related to vessel co-option and immune-related factors (lymphatic vessels, lymphocytes, and neutrophils). In conclusion, HGPs and vascular mechanisms characterize iCCA (sub)types and vessel co-option linked to the immune microenvironment.
Funder
Japan Health Sciences Foundation
Kaken Pharmaceutical
Kanazawa University
Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Brindley PJ, Bachini M, Ilyas SI, Khan SA, Loukas A, Sirica AE, Teh BT, Wongkham S, Gores GJ (2021) Cholangiocarcinoma. Nat Rev Dis Primers 7(1):65
2. Nakanuma Y, Klimstra D, Komuta M, and Zen Y (2019) Intrahepatic cholangiocarcinoma in World Health Organization classification of tumours. Digestive System Tomours (ed. W.C.o.T.E. Board) 254–259 (International Angency for Research on Cancer(IARC), Lyon(France), 2019)
3. Nakanuma Y, Miyata T, Uchida T (2016) Latest advances in the pathological understanding of cholangiocarcinomas. Expert Rev Gastroenterol Hepatol 10(1):113–127
4. Chung T, Park YN (2022) Up-to-date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma. Front Med (Lausanne) 9:857140
5. Zen Y (2023) Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities. Hum Pathol 132:197–207